Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus

NCT00597506 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Adenocarcinoma

Interventions

DRUG: Bevacizumab
DRUG: Everolimus

Sponsor

Herbert Hurwitz

Collaborators

[object Object]
[object Object]